• Non ci sono risultati.

Pharmacogenetics of oral anticoagulant therapy

N/A
N/A
Protected

Academic year: 2021

Condividi "Pharmacogenetics of oral anticoagulant therapy"

Copied!
1
0
0

Testo completo

(1)

119

RIMeL / IJLaM 2009; 5 (Suppl.)

Ricevuto: 15-07-2009 Pubblicato on-line: 11-09-2009

Pharmacogenetics of oral anticoagulant therapy

G. Lippi

Laboratorio di Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma, Italia

Corrispondenza a: Prof. Giuseppe Lippi, Laboratorio di Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria, via Gramsci n. 14, 43100 Parma, Italia. E-mail: giuseppe.lippi@univr.it

Oral anticoagulant therapy (OAT) based on coumarins (warfarin, Coumadin) and other vitamin K antagonists (ace- nocoumarol, Syntrom) has been the cornerstone of pre- vention and treatment of several thrombotic disorders, and these compounds are still the most used anticoagulant medications worldwide. Warfarin is a racemic mixture of two optically active enantiomers; S-warfarin is prevalently metabolized by the CYP2C9 enzyme of the cytochrome P450 system, whereas R-warfarin is cleared by the two cytochrome enzymes 1A2 and 3A4 (CYP1A2 and CYP3A4). Warfarin and other coumarins produce their anticoagulant effect by contrasting the cyclic inter-conver- sion of vitamin K to its 2,3 epoxide. The enzymes vitamin K epoxide reductase (VKOR) and vitamin K reductase are essential in this process, because they reduce the vita- min K 2,3-epoxide to the active vitamin K quinole co- factor.

The management of OAT is difficult, due to considera- ble variability in the dose-response which can be ascribed to environmental, demographical, clinical and genetic va- riables. Predicting individual responses to the therapy re- presents a major challenge, and patients may be exposed to adverse heath outcomes from bleeding or thrombosis due to over- and undercoagulation. However, several li- nes of evidence indicates that up to 60% of the individual pharmacological response might be genetically regulated and influenced by single nucleotide polymorphisms in the

genes encoding VKOR and cytochrome P450 CYP2C9.

Therefore, genetic testing is currently regarded as a promi-

sing tool to help predict dose response during initial anti-

coagulation, assess dose maintenance variability, and iden-

tify warfarin resistance. Nevertheless, pharmacogenetics of

OAT can not be considered as yet the “magic bullet”, cur-

rent limitations including a suitable organization of genetic

panels, a limited amount of information about inter-indi-

vidual variability, a lack of analytical and quality specifica-

tions, a partial availability of outcome analyses that une-

quivocally confirm cost-effectiveness, a lack of universal

agreement related to reliable dosing algorithms and other

ethical and social issues. Therefore, it seems reasonable to

conclude that it is premature to introduce routine OAT

pharmacogenetics in the daily practice, though the deve-

lopment and clinical validation of simple but comprehen-

sive algorithms integrating the most informative gene poly-

morphisms, along with demographical (age, race, body

mass index) and clinical variables (comorbidities, drugs

interference) as well as a standardized dietary intake of

vitamin K, may provide a valuable tool in the individually

managed care of patients on OAT. It is also to consider

that the forthcoming commercialization of new anticoa-

gulant drugs targeting thrombin and factor X will introdu-

ce a paradigm shift in long-term anticoagulation therapy,

where consideration could be given to demise pharmaco-

genetics testing for OAT.

Riferimenti

Documenti correlati

BM and therefore neonatal intestinal microbiota can be influenced by several factors, as reported in Table 1, including genetics (such as secretor status, as previously

Region of interest (ROI)-based Pearson correlation between drug-induced neurochemical and hemodynamic response patterns shows an anatomical heterogeneity underlying the

Nel presente saggio vorrei fornire alcuni spunti di riflessione per una ricon- siderazione del langhiano Frau im Mond, non tanto a partire da un’improbabile rivisitazione dei

There was an interaction between uterine disease and time (P = 0.14) on plasma cortisol concentrations, which showed that metritis cows had greater (P = 0.04) plasma concentration

, il quale impone che tutti i provvedimenti limitativi della libertà personale debbano essere adottati dall‟autorità giudiziaria nei soli casi e modi previsti dalla

If we consider the neutron flux expressed as a linear combination of basis functions, from the linearity of the transport equation, we can obtain a linear combination of burnup

Mentre negli anni passati, queste cinque ricerche sono state effettuate su un’indindagine chiamata ’’ Identità, bisogni e ricognizione strutturale dei dati sul